-
唐冰
外科 燒傷科
醫(yī)生介紹
研究方向:燒傷、整形、創(chuàng)面修復(fù)和瘢痕防治 主要教育和工作經(jīng)歷:本科畢業(yè)于中山醫(yī)科大學(xué)臨床醫(yī)學(xué)系,中山大學(xué)外科學(xué)博士,美國(guó)德州大學(xué)MD Anderson腫瘤中心訪問(wèn)學(xué)者。中山大學(xué)附屬第一醫(yī)院工作至今。 社會(huì)兼職:國(guó)家衛(wèi)生應(yīng)急處置指導(dǎo)專(zhuān)家;廣東省杰出青年醫(yī)學(xué)人才(第一批);國(guó)家、廣東、江蘇省自然科學(xué)基金;河北、江西、四川科技獎(jiǎng)勵(lì)評(píng)審專(zhuān)家;國(guó)際燒傷學(xué)會(huì)(ISBI)會(huì)員;中華醫(yī)學(xué)會(huì)燒傷外科分會(huì)創(chuàng)面修復(fù)學(xué)組委員;中國(guó)醫(yī)學(xué)裝備協(xié)會(huì)創(chuàng)面修復(fù)分會(huì)常務(wù)委員;中國(guó)非公立醫(yī)療機(jī)構(gòu)協(xié)會(huì)損傷與修復(fù)專(zhuān)委會(huì)常委;中國(guó)研究型醫(yī)院學(xué)會(huì)創(chuàng)面防治與損傷組織修復(fù)專(zhuān)委會(huì)委員;中國(guó)研究型醫(yī)院學(xué)會(huì)生物材料臨床應(yīng)用專(zhuān)業(yè)委員會(huì)委員;廣東省臨床醫(yī)學(xué)學(xué)會(huì)-華南名醫(yī)專(zhuān)委員會(huì)會(huì)員 論著: 1. Application of 3D Printed Models of Complex Hypertrophic Scars for Preoperative Evaluation and Surgical Planning. Front Bioeng Biotechnol. 2020; 8: 115. doi: 10.3389/fbioe.2020.00115 (IF: 5.12, 通訊作者) 2. In situ formed anti-inflammatory hydrogel loading plasmid DNA encoding VEGF for burn wound healing. Acta Biomaterialia.2019; 100:191-201. (IF: 6.64, 通訊作者) 3. Fibronectin precoating wound bed enhances the therapeutic effects of autologous epidermal basal cell suspension for full-thickness wounds by improving epidermal stem cells’ utilization. Stem Cell Research & Therapy. 2019;10:0-154. (IF: 4.63, 通訊作者) 4. Preparation and characterisation of a novel silk fibroin/hyaluronic acid/sodium alginate scaffold for skin repair. Int J Biol Macromol. 2019;130:58-67. (IF:3.91) 5. Efficacy and safety of platelet-rich plasma for patients with diabetic ulcers: A systematic review and meta-analysis. Adv Wound Care (New Rochelle). 2019;8(7):298-308. (IF: 3.71, 通訊作者) 6. Three-dimensional digital reconstruction of skin epidermis and dermis. J Microsc. 2017 Dec 14. doi: 10.1111/jmi.12671. (IF: 1.9, 通訊作者) 7. Randomized clinical trial of autologous skin cell suspension for accelerating re-epithelization of split-thickness donor sites. Brit J Surg. 2017;104:836-842. (IF: 5.59,通訊作者) 8. Transforming growth factor-beta inducible early gene-1 (TIEG1) represses Smad7-mediated activation of TGF-β1/Smad signaling in keloid pathogenesis. J Invest Dermatol. 2017;137:1051-1059. (IF: 6.287, 通訊作者) 9. Pleiotropic FTY720 is a specific and potent therapy for hypertrophic scar. J Invest Dermatol. 2017;137:1552-1561. (IF: 6.287, 通訊作者) 10. KMT2A promotes melanoma cell growth by targeting ...
醫(yī)生擅長(zhǎng)
從事燒傷、整形、創(chuàng)面修復(fù)和瘢痕防治的臨床和研究工作。危重?zé)隣C傷,高壓電擊傷、化學(xué)燒傷、及放射性損傷等治療。燒傷后瘢痕及瘢痕疙瘩保守及整形手術(shù)治療。慢性難治性創(chuàng)面治療。體表腫物、血管瘤、黑色素瘤、皮膚癌的整形修復(fù)手術(shù)。自體細(xì)胞移植,美容修復(fù)。